Skip to main content
SpringerLink
Log in

Pluriglanduläre endokrine Regulationsstörungen

  • Chapter
  • First Online:
Pathologie

Part of the book series: Pathologie ((PATHOL))

  • 5988 Accesses

Zusammenfassung

Das Kapitel behandelt die multiplen endokrinen Neoplasien Typ 1 und Typ 2 mit ihren Unterformen und gibt einen kurzen Überblick über weitere Syndrome mit endokrinen Neoplasien. Neben Ätiologie, Pathogenese und Genetik werden die typische Lokalisation sowie Morphologie der Befunde zusammen mit der klinischen Symptomatik, dem Verlauf und der Prognose beschrieben. In einem zweiten Teil werden die pluriglanduläre endokrine Insuffizienz und deren zwei typische Unterformen abgehandelt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 469.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  1. Albores-Saavedra JA, Krueger JE (2001) C-cell hyperplasia and medullary thyroid microcarcinoma. Endocr Pathol 12:365–377

    Article  CAS  PubMed  Google Scholar 

  2. Anlauf M, Enosawa T, Henopp T, Schmitt A, Gimm O, Brauckhoff M, Dralle H, Musil A, Hauptmann S, Perren A, Klöppel G (2008) Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor. Am J Surg Pathol 32:1101–1105

    Article  PubMed  Google Scholar 

  3. Anlauf M, Garbrecht N, Henopp T, Schmitt A, Schlenger R, Raffel A, Krausch M, Gimm O, Eisenberger CF, Knoefel WT, Dralle H, Komminoth P, Heitz PU, Perren A, Kloppel G (2006) Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J Gastroenterol 12:5440–5446

    PubMed Central  PubMed  Google Scholar 

  4. Anlauf M, Perren A, Henopp T, Rudolf T, Garbrecht N, Schmitt A, Raffel A, Gimm O, Weihe E, Knoefel WT, Dralle H, Heitz PU, Komminoth P, Kloppel G (2007) Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions. Gut 56:637–644

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD (1990) Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322:1836–1841

    Article  CAS  PubMed  Google Scholar 

  6. Belar O, De La Hoz C, Perez-Nanclares G, Castano L, Gaztambide S (2011) Novel mutations in MEN1, CDKN1B and AIP genes in patients with multiple endocrine neoplasia type 1 syndrome in Spain. Clin Endocrinol (Oxf) 76:719–724

    Article  Google Scholar 

  7. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr., Marx SJ (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658–5671

    Article  CAS  PubMed  Google Scholar 

  8. Cadiot G, Laurent PP, Thuille B, Lehy T, Mignon M, Olschwang S (1993) Is the multiple endocrine neoplasia type 1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome? Gastroenterology 105:579–582

    CAS  PubMed  Google Scholar 

  9. Calender A, Morrison C, Komminoth P, Scoazec J, Sweet K, Eng C (2004) Inherited tumor syndromes. In: DeLellis R, Heitz P, Lloyd R, Eng C (Hrsg) WHO classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, S 209–261

    Google Scholar 

  10. Carpenter CC, Solomon N, Silverberg SG, Bledsoe T, Northcutt RC, Klinenberg JR, Bennett IL Jr., Harvey AM (1964) Schmidt’s syndrome (thyroid and adrenal insufficiency). a review of the literature and a report of fifteen new cases including ten instances of coexistent diabetes mellitus. Medicine (Baltimore) 43:153–180

    CAS  Google Scholar 

  11. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi S, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Crabtree JS, Wang Y, Roe BA, Weisemann J, Boguski MS, Agarwal SK, Kester MB, Kim YS, Heppner C, Dong Q, Spiegel AM, Burns AL, Marx SJ (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404–406

    Article  CAS  PubMed  Google Scholar 

  12. Clerici T, Schmid C, Komminoth P, Lange J, Spinas GA, Brändle M (2001) 10 Swiss kindreds with multiple endocrine neoplasia type 1: Assessment of screening methods. Swiss Med Wkly 131:381–386

    CAS  PubMed  Google Scholar 

  13. DeLellis RA (1995) Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic and molecular features. Lab Invest 72:494–505

    CAS  PubMed  Google Scholar 

  14. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214

    Article  PubMed  Google Scholar 

  15. Donow C, Pipeleers-Marichal M, Schroder S, Stamm B, Heitz PU, Kloppel G (1991) Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer 68:1329–1334

    Article  CAS  PubMed  Google Scholar 

  16. Heitz PU, Steiner H (1981) Pluriglanduläre endokrine Regulationsstörungen. In: Doerr W, Seifert G, Uehlinger E (Hrsg) Pathologie der endokrinen Organe. Springer, Berlin, S 1137–1203

    Chapter  Google Scholar 

  17. Hofstra RMW, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JWM, Ploos van Amstel HK, Romeo G, Lips CJM, Buys CHCM (1994) A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375–376

    Article  CAS  PubMed  Google Scholar 

  18. Kato H, Uchimura I, Morohoshi M, Fujisawa K, Kobayashi Y, Numano F, Goseki N, Endo M, Tamura A, Nagashima C (1996) Multiple endocrine neoplasia type 1 associated with spinal ependymoma. Intern Med 35:285–289

    Article  CAS  PubMed  Google Scholar 

  19. Klöppel G, Höfler H, Heitz PU (1993) Pancreatic endocrine tumours in man. In: Polak JM (Hrsg) Diagnostic histopathology of neuroendocrine tumours. Churchill Livingstone, Edinburgh, S 91–121

    Google Scholar 

  20. Klöppel G, Willemer S, Stamm B, Häcki WH, Heitz PU (1986) Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I. An immunocytochemical study of nine patients. Cancer 57:1824–1832

    Article  PubMed  Google Scholar 

  21. Koch CA, Mauro D, Walther MM, Linehan WM, Vortmeyer AO, Jaffe R, Pacak K, Chrousos GP, Zhuang Z, Lubensky IA (2002) Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2. Endocr Pathol 13:17–27

    Article  CAS  PubMed  Google Scholar 

  22. Komminoth P (1997) Multiple endokrine Neoplasie Typ 1 und 2. Diagnostische Leitlinien und molekulare Pathologie 1997. Pathologe 18:286–300

    Article  CAS  PubMed  Google Scholar 

  23. Komminoth P (1997) The RET proto-oncogene in medullary and papillary thyroid carcinoma. Molecular features, pathophysiology and clinical implications. Virchows Arch 431:1–9

    Article  CAS  PubMed  Google Scholar 

  24. Komminoth P (1999) Multiple endocrine neoplasia type 1, sporadic neuroendocrine tumors and MENIN. Diagn Mol Pathol 8:107–112

    Article  CAS  PubMed  Google Scholar 

  25. Komminoth P (2000) A 5178G->A splice donor site mutation in intron 4 of the MEN1 gene causing multiple endocrine neoplasia type 1. Int J Cancer 87:306–307

    Article  CAS  PubMed  Google Scholar 

  26. Komminoth P, De Krjiger R, Tischler A (2002) Paraganglia and the adrenal medulla. In: LiVolsi V, Asa S (Hrsg) Endocrine Pathology. Churchill Livingstone, New York, S 149–169

    Google Scholar 

  27. Komminoth P, Heitz PU, Klöppel G (1998) Pathology of MEN-1: Morphology, clinicopathologic correlations and tumor development. Int J Med 243:455–464

    Article  CAS  Google Scholar 

  28. Komminoth P, Heitz PU, Klöppel G (2000) Multiple endocrine disorders. In: Stefaneanu LS, Sasano HS, Kovacs K (Hrsg) Molecular and cellular endocrine pathology. Arnold, London, S 375–400

    Google Scholar 

  29. Komminoth P, Kunz EK, Matias-Guiu X, Hiort O, Christiansen G, Colomer A, Roth J, Heitz PU (1995) Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas. Cancer 76:479–489

    Article  CAS  PubMed  Google Scholar 

  30. Komminoth P, Muletta-Feurer S, Soltermann A, Gemsenjäger E, Bürgi H, Staub JJ, Schönle E, Fried M, Vetter W, Spinas GA, Heitz PU (1996) Detection of RET-proto-oncogene mutations in the diagnosis of type 2 endocrine neoplasia (MEN 2). Schweiz Med Wochenschr 126:1329–1338

    CAS  PubMed  Google Scholar 

  31. Koncz E, Schmid KW (2010) Multiple endocrine neoplasia type I. Pathologe 31:445–448

    Article  CAS  PubMed  Google Scholar 

  32. Kumar PG, Laloraya M, She JX (2002) Population genetics and functions of the autoimmune regulator (AIRE). Endocrinol Metab Clin North Am 31:321–338

    Article  CAS  PubMed  Google Scholar 

  33. Lee M, Pellegata NS (2013) Multiple endocrine neoplasia syndromes associated with mutation of p27. J Endocrinol Invest 36:781–787

    CAS  PubMed  Google Scholar 

  34. Lee M, Pellegata NS (2013) Multiple endocrine neoplasia type 4. Front Horm Res 41:63–78

    Article  CAS  PubMed  Google Scholar 

  35. Molatore S, Pellegata NS (2010) The MENX syndrome and p27: relationships with multiple endocrine neoplasia. Prog Brain Res 182:295–320

    Article  CAS  PubMed  Google Scholar 

  36. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458–460

    Article  CAS  PubMed  Google Scholar 

  37. Neufeld M, Maclaren NK, Blizzard RM (1981) Two types of autoimmune Addison’s disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 60:355–362

    Article  CAS  Google Scholar 

  38. Padberg B, Schröder S, Capella C, Frilling A, Klöppel G, Heitz PU (1995) Multiple endocrine neoplasia type 1 (MEN 1) revisited. Virchows Arch 426:541–548

    Article  CAS  PubMed  Google Scholar 

  39. Perren A, Anlauf M, Henopp T, Rudolph T, Schmitt A, Raffel A, Gimm O, Weihe E, Knoefel WT, Dralle H, Heitz PU, Komminoth P, Kloppel G (2007) Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas. J Clin Endocrinol Metab 92:1118–1128

    Article  CAS  PubMed  Google Scholar 

  40. Peterson P, Pitkanen J, Sillanpaa N, Krohn K (2004) Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity. Clin Exp Immunol 135:348–357

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  41. Pipeleers MM, Somers G, Willems G, Foulis A, Imrie C, Bishop AE, Polak JM, Hacki WH, Stamm B, Heitz PU et al (1990) Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome [see comments]. N Engl J Med 322:723–727

    Article  Google Scholar 

  42. Santamaria P, Barbosa JJ, Lindstrom AL, Lemke TA, Goetz FC, Rich SS (1994) HLA-DQB1-associated susceptibility that distinguishes Hashimoto’s thyroiditis from Graves’ disease in type I diabetic patients. J Clin Endocrinol Metab 78:878–883

    CAS  PubMed  Google Scholar 

  43. Sheu SY, Schmid KW (2010) Multiple endocrine Neoplasien Typ 2. Pathologe 31:449–454. Erratum in: Pathologe (2011) 32:82

    Article  PubMed  Google Scholar 

  44. Scheithauer BW, Laws EJ, Kovacs K, Horvath E, Randall RV, Carney JA (1987) Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin Diagn Pathol 4:205–211

    CAS  PubMed  Google Scholar 

  45. Schröder S, Padberg BC (1991) Pathologie der multiplen endokrinen Neoplasien 2A und 2B – eine aktuelle Bestandsaufnahme. Pathologe 12:131–137

    PubMed  Google Scholar 

  46. Solcia E, Capella C, Fiocca R, Rindi G, Rosai J (1990) Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. Am J Surg Pathol 14:503–513

    Article  CAS  PubMed  Google Scholar 

  47. Stolte M, Rüschoff J, Klöppel G (2013) Pathologie. Verdauungstrakt und Peritoneum. Springer, Berlin

    Google Scholar 

  48. Szinnai G, Meier C, Komminoth P, Zumsteg UW (2003) Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis. Pediatrics 111:E132–139

    Article  PubMed  Google Scholar 

  49. Tait KF, Gough SC (2003) The genetics of autoimmune endocrine disease. Clin Endocrinol (Oxf) 59:1–11

    Article  CAS  Google Scholar 

  50. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S, Lips K, Monson JP, Ohalloran D, Sampson J, Shalet SM, Wheeler MH, Zink A, Thakker RV (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Qjm Mon J Assoc Physician 89:653–669

    Article  CAS  Google Scholar 

  51. Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F, Neumann HP (2010) Multiple endocrine neoplasia type 2. Best Pract Res Clin Endocrinol Metab 24:371–387

    Article  CAS  PubMed  Google Scholar 

  52. Vogel A, Strassburg CP, Obermayer-Straub P, Brabant G, Manns MP (2002) The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. J Mol Med 80:201–211

    Article  CAS  PubMed  Google Scholar 

  53. Welander J, Soderkvist P, Gimm O (2011) Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer 18:R253–276

    Article  CAS  PubMed  Google Scholar 

  54. Wolfe H, Melvin K, Cervi-Skinner S, Al Saadi A, Juliar J, Jackson C, Tashjian A (1973) C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 289:437–441

    Article  CAS  PubMed  Google Scholar 

  55. Yang YJ, Song TY, Park J, Lee J, Lim J, Jang H, Kim YN, Yang JH, Song Y, Choi A, Lee HY, Jo CH, Han JW, Kim ST, Youn HD, Cho EJ (2013) Menin mediates epigenetic regulation via histone H3 lysine 9 methylation. Cell Death Dis 4:e583

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinikum rechts der Isar, Konsultationszentrum für Pankreas- und endokrine Tumoren, Institut für Pathologie, Technische Universität München, Ismaningerstr. 22, 81675, München, Deutschland

    Günter Klöppel Prof. em. Dr. med.

  2. Nagelfluh, Austr. 50, 8804, Au / ZH, Schweiz

    Ph. U. Heitz Prof. Dr.

  3. Institut für Pathologie, Stadtspital Triemli, Birmensdorferstr. 497, 8063, Zürich, Schweiz

    Paul Komminoth Prof. Dr.

Authors
  1. Paul Komminoth Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ph. U. Heitz Prof. Dr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Günter Klöppel Prof. em. Dr. med.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul Komminoth Prof. Dr. .

Editor information

Editors and Affiliations

  1. Abt. Nephropathologie, Pathologisches Institut Universität Erlangen-Nürnberg, Erlangen, Germany

    Kerstin Amann

  2. Klinisches Institut für Pathologie, Medizinische Universität Wien Allg. Krankenhaus der Stadt Wien, Wien, Austria

    Renate Kain

  3. Konsultationszentrum für Pankreas- und Endokrine Tumoren, Institut für Pathologie, Ismaninger Str. 22, 81675, Technische Universität München Klinikum rechts der Isar, München, Germany

    Günter Klöppel

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Komminoth, P., Heitz, P.U., Klöppel, G. (2016). Pluriglanduläre endokrine Regulationsstörungen. In: Amann, K., Kain, R., Klöppel, G. (eds) Pathologie. Pathologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04566-0_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04566-0_25

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04565-3

  • Online ISBN: 978-3-642-04566-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation